Since the first report about cytoplasmic nucleophosmin (NPM) in acute myelogenous leukemia with a normal karyotype was announced, the shuttling activity of NPM and its proper subcellular localization have drawn many attentions. Mechanisms that regulate nucleocytoplasmic transport of proteins may provide novel opportunities for drug development. Here we show that, in Jurkat cells, strong fluorescence density of NPM prevails in the nucleus, while, some key nucleoporins: Nup88 and Nup214 localize mainly in the cytoplasm. Deguelin, a natural occurring rotenoid, presents powerful anti-leukemia effects through proliferation inhibition and apoptosis induction in Jurkat cells. Deguelin downregulates the expression of NPM, Nup88 and Nup214 in a dose-dependent manner and reverts the localization of Nup88 and Nup214 to nuclear rim. These results suggest that deguelin exhibit its strong anti-leukemia effects might through the regulation of some nucleoporins, thus influence the subsequent abnormal expressions or localizations of some key proteins involved in proliferation and/or apoptosis, such as: NPM.
Nucleophosmin (NPM) was first identified as a nucleolar phosphoprotein expressed at high levels in the granular region of the nucleolus. 1) NPM has been proved to be a multifunctional protein that is involved in several cellular processes, including ribosome biogenesis, centrosome duplication, cell cycle progression, cell growth, and transformation.
2) NPM is implicated in human tumorigenesis, but the function of NPM in tumorigenesis is much confusing, it might be related to both oncogenic and tumour-suppressing pathways, depending on its dosage and level of expression. The NPM gene (NPM1) locus is involved in chromosomal translocations or deletions or mutations in various kinds of haematological malignancies.
3) Strikingly, NPM1 has also recently been found to be mutated and aberrantly localized in the cytoplasm of leukemia blasts in a high proportion (around 35%) of patients with acute myeloid leukemia (AML), which makes NPM1 one of the most frequently mutated genes in AML. 4) Although the bulk of NPM resides in the granular region of the nucleolus, NPM shuttles continuously between the nucleus and cytoplasm. 5) The shuttling activity of NPM and its proper subcellular localization might be crucial for cellular homeostasis. Nuclear import and nuclear export mechanisms that govern the nucleocytoplasmic distribution of macromolecules are regulated at multiple levels. However, nuclear pore complex (NPC), as the only gateway, might produce a marked effect. The NPC is composed of multiple copies of proteins called nucleoporins. In vertebrate cells, about 30 nucleoporins have been identified. 6) However, the function of many individual nucleoporins in different transport pathways is largely unresolved. Nup88, a protein is putatively involved in nuclear-cytoplasmic transport and localized preferentially at the nuclear membrane, is found to be overexpressed in a series of tumor cell lines and primary human solid tumors. [7] [8] [9] CAN, also called Nup214, is a nuclear pore complex (NPC) protein that interacts at the NPC with Nup88. Nup214 was first identified as a target for chromosomal translocations involved in leukemogenesis, and has also been suggested to be involved in proteins transport, nuclear mRNA export, and cell cycle regulation. 10, 11) Furthermore, variation in levels of the Nup88/Nup214 complex influences the relative strength and duration of NF-kB signaling responses. 12) Since the important roles in the nucleocytoplasmic transport and tumorigenesis, Nup214/Nup88 complex might also contribute to the transport of NPM or some other key proteins involved in the genesis or development of leukemia. Mechanisms that regulate nucleocytoplasmic transport of proteins may provide novel opportunities for drug development.
Deguelin, a rotenoid isolated from several plant species including Mundulea sericea (Leguminosae) has been shown to be a strong anti-tumor and cancer chemopreventive agent through PI3K/Akt pathway inhibition in several mammalian cell culture systems. 13, 14) Our earlier studies have also shown that deguelin presents its powerful antileukemia activity through the modulation of cell cycle regulative proteins or NF-kB signal pathway in vitro. 15, 16) However, the effect and mechanism of action of deguelin on T cell leukemia is not well known. It is our interest to investigate whether the antitumor activity of deguelin on T cell leukemia is association with the blockade of constitutively active of nucleoporins: Nup88 and Nup214, thus influences the subsequent nucleocytoplasmic transport of shuttling proteins, such as: NPM.
MATERIALS AND METHODS

Materials
Jurkat cell line is obtained from the China Center for Typical Culture Collection (Wuhan, China) and maintained in RPMI-1640 (Sigma) medium supplemented with 10% fetal bovine serum (FBS, Gibco-BRL, U.S.A.) at 37°C in a humidified atmosphere. Deguelin is purchased from the Alexis (Läufelfingen, Switzerland). Anti-NPM antibody is purchased from Zymed, San Francisco, Calif. Antibodies specific to Nup88, Nup214, GAPDH and HRP-conjugated secondary antibodies are all from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A. DNA Fragmentation Assay DNA is isolated according to the method described in the DNA apoptosis ladder kit. Cells are washed and lysed in 300 ml of digestion buffer after 24 h and/or 48 h culture. The genomic DNA is dissolved in TE buffer and 5 mg of DNA samples is subjected to agarose gel (2%) electrophoresis. The gels are visualized and photographed under UV light.
Annexin-V Fluorescein Isothiocyanate/Propidium Iodide (FITC/PI) Staining for Evaluation of Apoptosis
According to the method described in Annexin-V FITC detection kit, cells are washed and resuspended in the binding buffer provided in the kit after 24 h culture. Afterwards, cells are stained with 5 ml Annexin-V FITC solution and 10 ml PI solution for 15 min at room temperature in the dark. Finally, the samples are diluted with 300 ml binding buffer and analyzed on a flow cytometer (FACSort; BD Biosciences) within 30 min.
Hoechst 33258 Staining Nuclear fragmentation is visualized by Hoechst 33258 staining of apoptotic nuclei. The apoptotic cells are collected, washed, and then fixed in 4% paraformaldehyde for 10 min at room temperature before deposition on polylysine-coated coverslips. The adhered cells are permeabilized with 0.1% Triton X-100 for 5 min at room temperature, and then incubated with Hoechst 33258 for 30 min at 37°C, rinsed with PBS and mounted on slides with glycerol-PBS. Finally, the cells are viewed with an Olympus BH-2 fluorescence microscope (Tokyo, Japan).
Preparation of Cell Lysates and Western Blot Analysis After treatment, Jurkat cells are harvested and lysed in 100 ml of lysis buffer by incubation on ice for 30 min, then, the extracts are centrifuged at 12000 rpm for 15 min at 4°C. After addition of sample loading buffer, protein samples are electrophoresed on a 12.5% sodium dodecylsulfate (SDS)-polyacrylamide gel and then transferred onto nitrocellulose membranes, probed with anti-NPM and anti-Nup88 antibodies (dilultion 1 : 1500) separately. After overnight incubation at 4°C, the blots are washed, and exposed to HRP-conjugated secondary antibodies (dilultion 1 : 1500) for 1 h. Finally, the blots are washed and detected with ECL substrate solution. Densitometric analysis is performed using Quantity One software.
Nup214 Protein Analysis Using Flow Cytometry
Flow cytometry is performed to determine the expression of Nup214 in Jurkat cells. A total of 1ϫ10 6 cells are collected and washed after 24 h culture, anti-Nup214 antibody (dilution 1 : 100) is added, the mixture is then kept at 4°C overnight. Mouse IgG1 (dilution 1 : 50) antibody is the isotype control group. FITC-labeled secondary antibody (diluted 1 : 100) is applied for 30 min at room temperature. Stained cells are analyzed on a flow cytometer. The percentage of cells is determined by the CellQuest software program.
RNA Isolation and Reverse Transcription-PCR Cells are lysed within Trizol reagent after 24 h culture, and total RNA is prepared. cDNA was synthesized according to the manufacturer's instruction of Fermentas kit. Twenty microliters PCR reaction mixture is amplified. The following primer pairs are designed from human cDNA sequences available in GenBank and synthesized by Shanghai Invitrogen Biotechnology Co., Ltd., China: Nup88 (GenBank accession no. Immunofluorescence with Confocal Microscopy For the immunofluorescence experiments, cells are fixed in 4% paraformaldehyde for 10 min and permeabilized with 0.2% Triton X-100 on ice for 10 min. Samples are blocked with 3% bovine serum albumin plus 0.02% Triton X-100 in PBS for 30 min, incubated with antibody against NPM or Nup88 or Nup214 (at a working dilution of 1 : 100) separately overnight at 4°C, then, FITC-labeled secondary antibody diluted in PBS is applied for 60 min. Hoechst 33258 (1 mg/ml) or PI (50 mg/l) is included in the penultimate wash step to visualize the DNA. Images are captured using a FV500 confocal microscope (Olympus, Tokyo, Japan).
Statistical Analysis Student's t-test and one-way analysis of variance are used to determine the statistical significance of differences between values for various experimental and control groups. p values Ͻ0.05 was considered a significant difference.
RESULTS
Effects of Deguelin on Proliferation of Jurkat Cells
The cytotoxicity of deguelin to Jurkat cells is calculated from the loss of cell viability using MTT assay. As shown in 
Effects of Deguelin on Apoptosis of Jurkat Cells
To address the role of deguelin in conferring sensitivity to apoptosis, Jurkat cells are exposed to increasing concentration of deguelin, and then detected with DNA fragmentation assay and Annexin-V FITC/PI double-labeled cytometry. As a consequence, deguelin induces DNA fragmentation ( Fig. 2A) and apoptotic cell death (Fig. 2B) becomes shrinkaged. While, the normal Jurkat cells present intact plasma membrane and order chromatin folding (Fig.  2C) .
Effects of Deguelin on the Regulation of NPM, Nup88 and Nup214 in Jurkat Cells
To study the mechanisms of anti-leukemia activity by deguelin, we first examine whether there exists constitutive deregulation of NPM protein in Jurkat cells. As a result, high protein level, as well as mRNA level of NPM appears in Jurkat cells compared with deguelin-treated cells (Figs. 3A, C) . However, deguelin induces a dose-dependent decline of NPM both at transcriptional level and translational level.
Since the important role of nucleoporins in the nucleocytoplasmic transport of macromolecules, we then study the expression of Nup88 and Nup214 in Jurkat cells. Same as above, deguelin also induces the declination of Nup88 and Nup214 at the mRNA level (Figs. 3A-C) .
Disposition of NPM, Nup88 and Nup214 in Jurkat Cells
To visualize the subcellular locations of NPM, Nup88 and Nup214 better, confocal microscope is used. We find NPM appears high fluorescence intensity in nucleus, especially in nucleoli, with an average optical density (OD) value being 220.02Ϯ14. 16 . Besides, most of NPM protein shuttles to cytoplasm during cell mitosis. When cultured with 40 nmol/l deguelin, the fluorescence density drops to 130.86Ϯ17.96 (Fig. 4A) . On the other hand, Nup88 and Nup214 are found to be dispersed diffusely in the cytoplasm and nuclear envelope, with the mean fluorescence densities being 148.29Ϯ27.40 and 161.80Ϯ22.19 separately. However, deguelin induces a dramatic decline in fluorescence density to 54.70Ϯ16.90 and 61.23Ϯ14.52 correspondingly. Moreover, both nucleoporins are relocated to the nuclear envelope (Figs. 4B, C) .
DISCUSSION
An emerging but still poorly explored link is that between nucleocytoplasmic transport and cell apoptosis, proliferation or differentiation, supporting the notion that nucleocytoplasmic transport of signal transducers and execution factors, may be a crucial and even essential aspect of cellular homeostasis. Mechanisms that regulate nucleocytoplasmic transport of proteins may provide novel opportunities for drug development.
Deguelin, a natural plant extract, isolated from plants in Mundulea sericea family, has been observed to inhibit tumor cell growth or induce cell apoptosis in several mammalian cell culture systems. However, the effect and mechanism of action of deguelin on T cell leukemia is not well known. In this study, we show that deguelin shows strong antiproliferative potency on Jurkat cells in a time-and dose-dependent manner, with IC 50 for 24 h being (46.03Ϯ0.13) nmol/l. Moreover, deguelin also presents potent apoptosis-induction activity with typical morphlogical changes associated with apoptosis. It suggests that deguelin is an effective anti-leukemia reagent through the ability of inducing growth-arrest and apoptosis.
Ample amount of evidence has implicated NPM deregulation in promoting tumor cell proliferation, differentiation and apoptosis. [17] [18] [19] In haematological malignancies, NPM is downregulated in HL-60 cells during retinoic acid-induced differentiation and sodium butyrate-induced apoptosis. 20, 21) Also, decreased expression of NPM is involved in phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced differentiation of K562 cells. 22) It is conceivable that high levels of NPM in malignant cells might support aberrant cell growth by sustaining the ribosome machinery, as well as promotion proliferation and inhibition of distinct pro-apoptotic pathways. 17) On the other hand, NPM1 is one of the most frequent targets of genetic alterations in hematological malignancies, especially in de novo AML. 4) Therefore, the complex behavior of NPM protein demands further studies, including the molecular mechanisms and biological consequences of its altered expression and localization. In this study, we have shown that NPM prevails in the nucleus, especially in the nucleoli of the Jurkat cells. However, deguelin induces a dramatic downregulation of NPM at transcriptional level. What's more, in deguelin-treated cells, NPM is found to be scattered more concentrated in the nucleoli with low fluorescence density. It is plausible to propose that NPM function as a proto-oncogene rather than an anti-oncogene in Jurkat cells.
Since the important role of nucleocytoplasmic transport of macromolecules in cellular homeostasis, we suggest the irregular transcription or subcellular localization of NPM, or other signal transducers and execution factors, might be the result of abnormal nucleocytoplasmic transport. It is reported recently that sumoylation of NPM regulated its subcellular localization and influences cell proliferation and survival. 23) However, as the only passage, NPC seems more essential for all the transports between nucleus and cytoplasm. NPC is an elaborate supramolecular structure consisting of about 30 different proteins, termed nucleoporins. 6) Nup88/Nup214, however, as the most common subcomplex of NPC, functions an important role during nucleocytoplasmic transport. Nup214 normally localizes to the cytoplasmic face of NPC, where it forms a subcomplex with the nucleoporin Nup88. Nup214 interacts with CRM1, a member of the importin b superfamily, and serves as the terminal step of export, suggesting Nup88/Nup214 complex is required for efficient CRM1-mediated transport. 11) In addition to mediating nucleocytoplasmic transport, Nup88 and Nup214 are both involved in the pathogenesis of tumors. Nup88 has been found over-expressed in human tumors of various derivations, especially in solid tumors Whereas, Nup214, the human CAN protein, has been found to be involved in several leukemiaspecific chromosome translocations, leads to expression of different fusion genes including DEK-CAN, CAN-ABL, TAF-1b-CAN and SET-CAN. 11, [24] [25] [26] Since the intimate relationship between nucleoporins and tumors, as well as nucleocytoplasmic transport, they might also contribute to the genesis of T cell leukemia. As we presume, concomitant with the upregulation of NPM, Nup88 and Nup214 are also found upregulated in Jurkat cells, what's more, they both prevail and situate diffusely in the cytoplasm and nuclear rim. However, deguelin induces downregulation of both two nucleoporins in a dose-dependent manner. Furthermore, Deguelin might relocate the subcellular disposition of Nup88 and Nup214 to the nuclear envelope in treated cells. Although the functional significance of this aberrant localization and expression is not yet known, we can imagine that downregulation of the two nucleoporins induces an obviously decreased proliferation rate and a dramatic increased apoptosis rate, as well as abnormal nuclear export efficiency. This is just consistent with the conclusions proposed by Hutten et al. 27) On the other hand, however, in drosophila, Nup88 anchors Nup214 and CRM1 on the nuclear envelope, attenuates nuclear export signal (NES)-mediated nuclear export, thereby results in the nuclear accumulation of NF-kB protein and full activation of the innate immune response. 12) We have no direct evidence to confirm the intimate interaction of the deregulation of Nup88/Nup214 complex with the high expression of NPM in Jurkat cells, yet, we reason that the high expression and disposition of Nup88/Nup214 complex induce an enhanced nucleocytoplasmic transport required to meet the increased proliferation rate and upregulated transcriptional activity of NPM in Jurkat cells. Deguelin, as a potent antileukemia agent, might rectify the deregulation of Nup88 and Nup214, thus influence the activities of cell proliferation and apoptosis.
Taken together, our results imply that deguelin also presents potent effects on growth-arrest and apoptosis-induction in Jurkat cells in vitro, which might be related to the regulation of nucleophosmin and some key nucleoporins, such as: Nup88 and Nup214. It may represent a new remedy for acute leukemia.
